General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 7.60
-0.85 (-10.06%)
Oct 20, 2026, 1:40 PM CST
General Biologicals Company Description
General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.
The company offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point-of-care testing services.
It also provides Oncology & Liquid Biopsy; blood safety and screening services for hepatitis and HIV; contract development and manufacturing; IVD reagents and biomaterials.
In addition, the company offers various oral care, skincare, and related health products under the oh care brand.
It serves its diagnostic and testing services through clinics and laboratories. General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.
General Biologicals Corporation
| Country | Taiwan |
| Founded | 1984 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 81 |
| CEO | Frank Lin |
Contact Details
Address: No. 6, Innovation First Road Hsinchu City, 300092 Taiwan | |
| Phone | 886 3 577 9221 |
| Website | gbc.com.tw |
Stock Details
| Ticker Symbol | 4117 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004117007 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Frank Lin M.B.A. | President and Director |
| Dr. C.M. Ling | Founder |
| Ming Shan Liu | Deputy General Manager of Sales Marketing and Director |